Literature DB >> 3535671

Applications of polysaccharides. Patents and literature.

R J Linhardt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535671     DOI: 10.1007/BF02798421

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


× No keyword cloud information.
  29 in total

1.  Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.

Authors:  M L Lepow; J S Samuelson; L K Gordon
Journal:  J Pediatr       Date:  1985-02       Impact factor: 4.406

2.  Type-specific antibody responses of volunteers immunized with 23-valent pneumococcal polysaccharide vaccine.

Authors:  M A Mufson; D Hughey; E Lydick
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

3.  Candida albicans polysaccharide extract (MPPS) and PPD stimulate the production of interleukin-1 and lymphocyte proliferation.

Authors:  G Lombardi; E Piccolella; D Vismara; V Colizzi; G L Asherson
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

4.  Antitumor effect of the yeast polysaccharide preparation in syngeneic mouse tumor models.

Authors:  N Kumano; S Suzuki; T Ishikawa; S Koinumaru; K Konno
Journal:  Tohoku J Exp Med       Date:  1985-05       Impact factor: 1.848

5.  Effect of indigestible polysaccharides on pancreatic exocrine secretion and biliary output.

Authors:  S Ikegami; H Harada; N Tsuchihashi; S Nagayama; E Nishide; S Innami
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  1984-12       Impact factor: 2.000

6.  C-polysaccharide in a pneumococcal vaccine.

Authors:  U B Sørensen; J Henrichsen
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1984-12

7.  Sulfated polysaccharides and cell differentiation in the sea urchin embryo.

Authors:  H Løvtrup-Rein; S Løvtrup
Journal:  Exp Cell Biol       Date:  1984

8.  Safety and immunogenicity of Haemophilus influenzae type B polysaccharide-diphtheria toxoid conjugate vaccine in adults.

Authors:  M L Lepow; J S Samuelson; L K Gordon
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

9.  Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

10.  Adjuvant effect of bacterial LPS and/or alum precipitation in responses to polysaccharide and protein antigens.

Authors:  I J Seppälä; O Mäkelä
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.